RSC is a partner with University of California San Francisco in the ASPIRE study on coronavirus research, focusing on the first trimester of pregnancy
Overview of the UCSF research study on COVID-19
The ASPIRE study (Assessing the Safety of Pregnancy In the CoRonavirus PandEmic) is being conducted to understand the effects of the dissemination of COVID-19 among pregnant women. The nationwide study is specifically looking at how the infection could potentially affect the well-being and health of pregnant women and their babies.
The ASPIRE study is being overseen by the University of California San Francisco (UCSF). As a partner in the study, Reproductive Science Center of the San Francisco Bay Area has been asked to help enroll qualified participants. The study was recently featured in the Wall Street Journal.
Focus is on first trimester of pregnancy when a baby is most vulnerable
The study is focusing on the first trimester of a woman’s pregnancy. The first trimester is a crucial period when the baby is the most vulnerable. This is when the organ systems develop and the placenta forms. The placenta creates the important connection between mother and baby.
As of now, there is no information or data about the effects of a mother being exposed to COVID-19 during the first trimester. The study will provide important information to:
- Help protect the safety of pregnant women and their unborn babies.
- Guide the care of women during their pregnancy.
- Those who are considering a future pregnancy and what it means to be pregnant during the era of COVID-19.
The study is looking to recruit 10,000 women at the start of their pregnancy. The participants have their potential COVID-19 exposure tracked frequently, using serology testing. Information will be collected during and after the pregnancy to try and discover what, if any, effects COVID-19 has for the mother and baby.
What are the requirements to participate in this COVID-19 medical research?
Participants must be over the age of 18. At the start of the study, participants must be four to ten weeks pregnant. Participants will be asked to complete the following tasks:
- Frequently submit symptom tracking reports using a mobile phone or computer (takes less than one minute).
- Collect blood samples on your own (via finger sticking) several times throughout the study.
- Give permission to the study team to review medical records that relate to your pregnancy, the baby’s development and your delivery.
- Complete online questionnaires about your overall health during the pregnancy and after delivering the baby.
FAQ about this coronavirus study
Q: How do I enroll in the ASPIRE study?
A: If you are a qualified participant, register here.
Q: Do I need to have had or currently have COVID-19 to participate?
A: No. ASPIRE is looking to enroll a broad range of pregnant women, regardless of COVID-19 infection or exposure.
Q: How long will it take to complete the study?
A: The study will take up to 26 months. During this time, you will complete the questionnaires through the pregnancy, delivery and until the baby is 18 months old, providing information on your baby’s development and overall heath.